Baudax Bio Non-Opioid Pain Drug Approval: In February, FDA granted approval to longtime Lotus client/ collaborator Baudax Bio’s non-opioid postsurgical pain therapy ANJESO. Lotus designed and performed both the Phase 2 and Phase 3 programs for this drug, with extensive scientific..
In September 2019, Lotus acquired HD Research, a network of specialty US analgesic research sites run by board certified anesthesiologists Harold Minkowitz, MD and David
At Lotus Clinical Research, the safety of our patients, employees and customers remains our highest priority.
In the coming weeks and months, in accordance with public health department…
September is Pain Awareness Month! Lotus Clinical Research’s mission is to reduce prescription drug misuse and abuse by inventing and validating scientific technologies that improve analgesic study design and conduct.
When it comes to subject dropouts, an ounce of prevention is worth a pound of cure. Lotus Clinical Research has created a subject and investigator education series that can reduce subject dropout rates.
The prevailing soft tissue acute pain surgical models (hemorrhoidectomy, herniorrhaphy, hysterectomy, laparoscopic cholecystectomy, colon surgery) are slow to recruit and present financial and logistical challenges
Bunionectomy as an Analgesic Model In analgesic clinical trials, selecting the type of model to use can be challenging as each has their own pros
Measuring Respiratory Depression in Analgesic Studies Demonstrating that a novel analgesic provides pain relief but does not cause respiratory depression can be a significant challenge.
3rd Molar Extraction as an Analgesic Model In analgesic clinical trials, selecting the type of model to use can be challenging as each has their
In analgesic clinical trials, managing placebo response can make the difference between a successful study and a false negative outcome.
© 2025 Lotus Clinical Research, LLC. All Rights Reserved
